RxDoctor Payments Data

Kevin Feng, OD

Optometrist · Princeton, NJNPI 1164090809

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $16,625 of the $25,538 with a category attached, or 65.1%. Bausch & Lomb Americas Inc. accounts for 85.2% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $17,329, 9.2 times the $1,875 reported in 2021. Among optometrist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,538in general payments, 2019–2025

Across 161 payments — averaging $158.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$22K
  • Alcon$736
  • Johnson & Johnson Vision Care, Inc.$702
  • Coopervision Inc.$638
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$390
  • Glaukos Corporation$216
  • plus $1K from 15 others

What the payments were for

  • Consulting fees$1,8507%
  • Speaking & faculty fees$16,62565%
  • Travel & lodging$3,46514%
  • Food & beverage$3,59814%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,538 in reported general payments places this provider in the 95th percentile of 1,357 optometrist providers in New Jersey.

See all optometrist providers in New Jersey

Medicare billing

Part B allowed, 2024
$84,794
Medicare patients
396
Services billed
764

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone14$717
Timolol Maleate11$161

Paid to pharmacies, not to this prescriber.

Other optometrist in Princeton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →